Publicaciones en las que colabora con JUAN JOSÉ TORRADO DURÁN (21)

2013

  1. Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations

    International Journal of Pharmaceutics, Vol. 447, Núm. 1-2, pp. 38-46

2008

  1. In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation

    Journal of Antimicrobial Chemotherapy, Vol. 61, Núm. 5, pp. 1125-1131

2007

  1. In vitro effect of new formulations of amphotericin B on amastigote and promastigote forms of Leishmania infantum

    International Journal of Antimicrobial Agents, Vol. 30, Núm. 4, pp. 325-329

2004

  1. Amphotericin B molecular organization as an essential factor to improve activity/toxicity ratio in the treatment of visceral leishmaniasis

    Journal of Drug Targeting, Vol. 12, Núm. 7, pp. 453-460

  2. Anti-leishmanial activity of a new formulation of amphotericin B

    Tropical Medicine and International Health, Vol. 9, Núm. 9, pp. 981-990

  3. Ex Vivo Anthelmintic Activity of Albendazole-Sulphoxide Enantiomers

    Journal of Parasitology, Vol. 90, Núm. 2, pp. 407-409

  4. Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres

    Antimicrobial Agents and Chemotherapy, Vol. 48, Núm. 9, pp. 3246-3252

2003

  1. Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole

    International Journal of Pharmaceutics, Vol. 250, Núm. 2, pp. 351-358

1999

  1. Preparation and characterization of albendazole β-cyclodextrin complexes

    Drug Development and Industrial Pharmacy, Vol. 25, Núm. 12, pp. 1241-1248

  2. Quantitative determination of albendazole and its main metabolites in plasma

    Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 723, Núm. 1-2, pp. 265-271

1998

  1. A selective and simple RP-HPLC assay to quantify albendazole metabolites in plasma

    Journal of Liquid Chromatography and Related Technologies, Vol. 21, Núm. 15, pp. 2327-2340